Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053567 · ClinicalTrials.gov registry record · Phase 3
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
A Phase 3 study of Nicotine Dependence, sponsored by Jasper A. Smits.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT06053567: Recruiting Phase 3 study of Nicotine Dependence, sponsored by Jasper A. Smits.
NCT06053567 is a Phase 3 study of Nicotine Dependence that is actively recruiting participants, run by Jasper A. Smits. The registered enrollment target is 360 participants, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (99% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053567, a Phase 3 study of Nicotine Dependence, is actively recruiting participants, sponsored by Jasper A. Smits.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA effective among racially/ethnically diverse samples?
Primary Outcome
Self-report of no smoking (not even a puff) during the previous 7 days, verified by expired carbon monoxide (CO; ≤5ppm), saliva cotinine (\<30 ng/mL), or significant other, and not invalidated by any of these verification measures. Failure to provide any of these 3 verification measures will result in PPA being considered missing.
Conditions Studied
Interventions
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Counseling
- DRUG Nicotine patch
Study Locations (1)
Texas
- University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-12-27 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 3 |
What NCT06053567 shows while recruiting
NCT06053567 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, above the 181-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (99% higher).
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Aerobic Exercise is the first listed.
NCT06053567 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06053567 about?
NCT06053567 is a clinical study titled "Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.". Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA e...
What is the current status of trial NCT06053567?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 360 participants. The study started on 2023-12-27. Estimated completion is 2028-06-30.
What conditions does trial NCT06053567 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT06053567?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Counseling (BEHAVIORAL), Nicotine patch (DRUG).
Who is sponsoring clinical trial NCT06053567?
This trial is sponsored by Jasper A. Smits, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053567 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06053567's enrollment target sits among peer trials
360 9th of 67 higher than 59 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Tobacco Use Treatment for PLWHA
RECRUITING · Phase 3
-
Smoking Treatment in HIV Clinical Care Settings
COMPLETED · Phase 3
-
Bupropion Treatment for Youth Smoking Cessation
COMPLETED · Phase 3
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI